Trials / Conditions / Clinical High Risk for Psychosis

Clinical High Risk for Psychosis

15 registered clinical trials studyying Clinical High Risk for Psychosis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Stratification and Treatment in Early Psychosis Study - PROMOTE NCT07434973	University of Oxford	Phase 3
Recruiting	Metacognitive Training in Ultra-high Risk NCT05827900	Medical University of Vienna	N/A
Recruiting	Sacramento Clinical High Risk for Psychosis Stepped-Care Program NCT06640803	University of California, Davis	N/A
Unknown	Endocannabinoid Activity Remodulation for Psychosis Liability in Youth NCT06037993	University of Udine	N/A
Completed	Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST) NCT05114733	Beth Israel Deaconess Medical Center	N/A
Completed	Feasibility of an Early Detection Program for Early Psychosis on a College Campus NCT03983421	University of New Mexico	—
Completed	The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis NCT04444180	Shanghai Mental Health Center	—
Completed	Glutamate Reducing Interventions in Schizophrenia NCT03321617	New York State Psychiatric Institute	Phase 1
Unknown	Evaluation of the Treatment Approach ROBIN NCT03829527	University of Zurich	N/A
Unknown	tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth NCT02951208	Centre for Addiction and Mental Health	N/A
Completed	Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings NCT03286595	University of California, Davis	N/A
Terminated	Gabapentin in Patients at Clinical Risk for Psychosis NCT02557945	New York State Psychiatric Institute	Phase 1 / Phase 2
Completed	Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis NCT02404194	Rush University Medical Center	N/A
Terminated	Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis NCT02047539	Yale University	EARLY_Phase 1
Completed	Using Mobile Technology to Enhance Early Psychosis Treatment Delivery NCT03303456	University of California, Davis	N/A